T. Yamada

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
T. Yamada, Tesshi Yamada
Publication record
198 papers · 10,762 citations · H-index 57

PAPERS

Malignant Melanoma Arising from Esophageal Melanosis and Synchronous with Esophageal Squamous Cell Carcinoma
20232 citationsauthor #5
Predicting the prognosis of lower rectal cancer using preoperative magnetic resonance imaging with artificial intelligence
20232 citationsauthor #7
Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
202211 citationsauthor #7
Structural Insight into TNIK Inhibition
202214 citationsauthor #3
Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment
20217 citationsauthor #12
Direct conversion of osteosarcoma to adipocytes by targeting TNIK
202117 citationsauthor #18
Circulating-tumor DNA from Two Types of Blood Collection Tubes for Monitoring Tumor Burden Validated with Esophageal Squamous Cell Carcinoma Patients
20200 citationsauthor #16
Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence.
202029 citationsauthor #12
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
202021 citationsauthor #15
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846
20201 citationsauthor #15
Abstract 5892: Whole-exome and RNA sequencing reveals chromosomal rearrangements associated with the recurrence of pulmonary carcinoid
20200 citationsauthor #12
Quantification of Biomarker Proteins Using Reverse‐Phase Protein Arrays
20202 citationsauthor #1
Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.
20200 citationsauthor #10
Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma
20208 citationsauthor #10
Feasibility of Targeting Traf2-and-Nck-Interacting Kinase in Synovial Sarcoma
202019 citationsauthor #2
Reverse Phase Protein Arrays: From Technical and Analytical Fundamentals to Applications
20191 citationsauthor #1
Biomarkers of Lung Cancer: Liquid Biopsy Comes of Age
20192 citationsauthor #3
Utility of Reverse-Phase Protein Array for Refining Precision Oncology.
20197 citationsauthor #2
Abstract 2284: Patient-specific circulating tumor DNA monitoring using esophageal squamous cell cancer gene panel and digital PCR
20190 citationsauthor #9
Abstract 1123: TRAF2 and NCK-interacting protein kinase (TNIK) regulates cancer stemness and adipogenesis of osteosarcoma cells
20180 citationsauthor #13
Therapeutic response monitoring using digital PCR for patient-specific circulating tumor DNA identified by an esophageal squamous cell carcinoma-specific sequencing panel.
20180 citationsauthor #7
Abstract 2034: Traf2-and Nck-interacting kinase (TNIK) inhibitor, NCB-0846, suppresses TGF-β1-induced epithelial-mesenchymal transition in lung cancer
20180 citationsauthor #8
Abstract B146: A novel TNIK inhibitor potently downregulates cancer stem cell population through attenuation of Wnt signaling
20182 citationsauthor #6
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy.
20178 citationsauthor #15
Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma.
201716 citationsauthor #12
Emergence of TNIK inhibitors in cancer therapeutics
201737 citationsauthor #1
Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
201747 citationsauthor #22
The emergence of TNIK as a therapeutic target for colorectal cancer
20179 citationsauthor #2
Signaling pathway profiling using reverse-phase protein array and its clinical applications
201714 citationsauthor #2
WNT Pathway Gene Mutations Are Associated With the Presence of Dysplasia in Colorectal Sessile Serrated Adenoma/Polyps
201754 citationsauthor #6
The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy
20179 citationsauthor #15
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
201692 citationsauthor #21
Abstract B17: Traf2- and NCK-interacting kinase (TNIK) inhibitor down-regulates Wnt signaling pathway in cancer cells
20160 citationsauthor #6
Possible utility of actinin-4 as a predictive biomarker of the efficacy of postoperative adjuvant chemotherapy for completely resected early stage lung adenocarcinoma.
20160 citationsauthor #13
Assessment of efficacy of adjuvant chemotherapy for non-small cell lung cancer with metastatic ability involving ACTN4
20160 citationsauthor #6
Pancreatic neuroendocrine tumors: A single-center 20-year experience with 100 patients.
201634 citationsauthor #10
A Novel TNIK inhibitor, N5355 potently induced apoptotic cell death through down-regulation of Wnt signaling
20161 citationsauthor #6
Plasma biomarker for detecting early stage and risk disease of pancreatic cancer by Apolipoprotein-A2 isoforms
20160 citationsauthor #19
Efficacy of adjuvant chemotherapy for non-small cell lung cancer assessed by metastatic potential associated with ACTN4
201625 citationsauthor #12
Targeting the Wnt signaling pathway in colorectal cancer
201664 citationsauthor #3
TNIK inhibition abrogates colorectal cancer stemness
2016139 citationsauthor #14
A phase I study of the combination of panitumumab and bevacizumab in KRAS wild-type colorectal cancer patients previously treated with fluoropyrimidine, oxaliplatin, irinotecan and bevacizumab
20161 citationsauthor #14
ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer
201530 citationsauthor #15
Therapeutic targets in the Wnt signaling pathway: Feasibility of targeting TNIK in colorectal cancer.
201579 citationsauthor #3
The alternatively spliced actinin-4 variant as a prognostic marker for metastasis in small-cell lung cancer.
201512 citationsauthor #14
Signaling pathway profiling by reverse-phase protein array for personalized cancer medicine.
201540 citationsauthor #2
Copy number of ACTN4 is a predictive indicator for late metastasis of cervical lymph nodes in early-stage tongue cancer
20150 citationsauthor #7
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
201576 citationsauthor #23
Hippo Pathway Gene Mutations in Malignant Mesothelioma: Revealed by RNA and Targeted Exon Sequencing
201598 citationsauthor #9
Proteomic analysis of ligamentum flavum from patients with lumbar spinal stenosis
201513 citationsauthor #9
68PTHE UTILITY OF ACTININ-4 PROTEIN OVEREXPRESSION AS A PREDICTIVE BIOMARKER FOR THERAPEUTIC EFFECT OF ADJUVANT CHEMOTHERAPY TO THE RESECTED LUNG ADENOCARCINOMA
20150 citationsauthor #7
α-Actinin-4 Enhances Colorectal Cancer Cell Invasion by Suppressing Focal Adhesion Maturation
201549 citationsauthor #3
409 Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies against apolipoprotein-AII isoforms
20150 citationsauthor #14
Alterations of the spindle checkpoint pathway in clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
201540 citationsauthor #14
Abstract 2316: Multilayer omics analyses in CpG island methylator phenotype clear cell renal cell carcinomas
20140 citationsauthor #8
Galectin-7 as a potential predictive marker of chemo-and/or radio-therapy resistance in oral squamous cell carcinoma
201424 citationsauthor #10
Histological growth pattern of and alpha-actinin-4 expression in thyroid cancer.
201416 citationsauthor #7
Copy number increase of ACTN4 is a prognostic indicator in salivary gland carcinoma
201433 citationsauthor #6
Alternative Mammalian Target of Rapamycin (mTOR) Signal Activation in Sorafenib-resistant Hepatocellular Carcinoma Cells Revealed by Array-based Pathway Profiling*
201456 citationsauthor #10
Abstract 4070: Functional differences of actinin isoforms in the formation of invadopodia by invasive cancer cells
20140 citationsauthor #6
Reverse Phase Protein Array: A Tool for Signaling Pathway Profiling in the Era of Genome Resequencing
20143 citationsauthor #1
Abstract 4679: Novel pathway mutations in malignant mesothelioma revealed by high-throughput DNA and RNA sequencing
20140 citationsauthor #7
Method of detecting tumor in the arc
20140 citationsauthor #6
MicroRNA Expression and Functional Profiles of Osteosarcoma
201439 citationsauthor #10
Use of phosphoprotein profiling with high-density fluorescence protein microarray to reveal a response predictor to a multikinase inhibitor sorafenib.
20130 citationsauthor #1
Abstract 2375: Prognostic significance of the alternatively splicedACTN4variant in high-grade neuroendocrine pulmonary tumors.
20130 citationsauthor #10
SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis
2013163 citationsauthor #9
Drifting EGFR mutation.
20131 citationsauthor #2
Abstract 4654: Genomic and proteomic profiling of signaling pathways targeted by a multi-kinase inhibitor, sorafenib.
20130 citationsauthor #3
Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.
201342 citationsauthor #16
Abstract A132: Development of a small-molecule inhibitor targeting the Wnt signaling pathway.
20130 citationsauthor #1
Soluble interleukin‐6 receptor is a serum biomarker for the response of esophageal carcinoma to neoadjuvant chemoradiotherapy
201346 citationsauthor #19
Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plasma for pancreatic cancer diagnosis.
201338 citationsauthor #6
Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
201366 citationsauthor #7
Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation
201315 citationsauthor #6
Abstract B265: Targeting Wnt signaling: Discovery and characterization of novel thiazole-based Traf2- and NCK-interacting kinase (TNIK) inhibitors.
20134 citationsauthor #7
Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer
201232 citationsauthor #12
Gene Amplification of ACTN4 in Lung Cancer: A Novel Prognostic Indicator for Stage I Adenocarcinoma of The Lung
20120 citationsauthor #10
2PT117 The prediction of three dimensional structure for mutants of actinin-4(The 50th Annual Meeting of the Biophysical Society of Japan)
20120 citationsauthor #5
β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
201234 citationsauthor #7
CHFR Protein Regulates Mitotic Checkpoint by Targeting PARP-1 Protein for Ubiquitination and Degradation*
201299 citationsauthor #5
Diagnostic and prognostic significance of the alternatively spliced ACTN4 variant in high-grade neuroendocrine pulmonary tumours.
201235 citationsauthor #14
Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation
201251 citationsauthor #19
Biomarker Discovery of Pancreatic and Gastrointestinal Cancer by 2DICAL: 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry
201215 citationsauthor #8
ACTN4 gene amplification and actinin‐4 protein overexpression drive tumour development and histological progression in a high‐grade subset of ovarian clear‐cell adenocarcinomas
201238 citationsauthor #8
Drifting EGFR mutation
20120 citationsauthor #2
Identification of 14-3-3γ as a Mieap-interacting protein and its role in mitochondrial quality control
20129 citationsauthor #8
Use of quantitative shotgun proteomics to identify fibronectin 1 as a potential plasma biomarker for clear cell carcinoma of the kidney
201118 citationsauthor #8
Combined functional genome survey of therapeutic targets for clear cell carcinoma of the kidney.
20110 citationsauthor #11
Targeting of Wnt Signaling Inside the Nucleus
20110 citationsauthor #2
Prediction of the efficacy of Neoadjuvant chemoradiotherapy for advanced esophageal cancer
20110 citationsauthor #7
CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis.
2011169 citationsauthor #5
MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression.
2011281 citationsauthor #8
Identification of Adipophilin as a Potential Plasma Biomarker for Colorectal Cancer Using Label-Free Quantitative Mass Spectrometry and Protein Microarray
201175 citationsauthor #19
Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray
201161 citationsauthor #21
Developments for a growing Japanese patient population: facilitating new technologies for future health care.
201115 citationsauthor #4
UP-01.179 Use of Quantitative Shotgun Proteomics to Identify Fibronectin 1 as a Novel Plasma Biomarker for Clear Cell Renal Cell Carcinoma
20111 citationsauthor #8
Traf2- and Nck-interacting kinase is essential for Wnt signaling and colorectal cancer growth.
2010116 citationsauthor #9
Abstract 1224: TNIK is a protein kinase essential for Wnt signaling and colorectal carcinogenesis
20100 citationsauthor #3
Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma
2010153 citationsauthor #11

TIMELINE

1985 51 citations

1988 1 citations

1995 1,313 citations

1996 35 citations

1997 101 citations

1998 554 citations

1999 136 citations

2000 917 citations

2001 365 citations

2002 625 citations

2003 653 citations

2004 266 citations

2005 1,238 citations

2006 225 citations

2007 457 citations

2008 402 citations

2009 318 citations

2010 503 citations

2011 620 citations

2012 313 citations

2013 375 citations

2014 171 citations

2015 437 citations

2016 356 citations

2017 194 citations

2018 2 citations

2019 10 citations

2020 80 citations

2021 24 citations

2022 25 citations

2023 4 citations

T. Yamada

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT